Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. The glymphatic system: implications for drugs for central nervous system diseases 2022-08-10
  2. Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs 2020-06-09
  3. Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs 2014-06-16

Studies

4 studies carry this tag.

Date range

2004 to 2022

Top journals

  • BioMed research international 1
  • Frontiers in neuroscience 1
  • Nature reviews. Drug discovery 1
  • The Journal of pharmacy and pharmacology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. The glymphatic system: implications for drugs for central nervous system diseases

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Nature reviews. Drug discovery 2022-08-10 Tau biomarkers

    In the past decade, evidence for a fluid clearance pathway in the central nervous system known as the glymphatic system has grown.

  2. Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Frontiers in neuroscience 2020-06-09 Tau biomarkers

    Central nervous system (CNS) disorders especially neurodegenerative disorders are the major challenge for public health and demand the great attention of researchers to protect people against them.

  3. Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. BioMed research international 2014-06-16 Biomarkers

    Chronic neuroinflammation is now considered one of the major factors in the pathogenesis of Alzheimer's disease (AD).

  4. Is nose-to-brain transport of drugs in man a reality?

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The Journal of pharmacy and pharmacology 2004-01-01 Tau biomarkers

    The blood-brain barrier that segregates the brain interstitial fluid from the circulating blood provides an efficient barrier for the diffusion of most, especially polar, drugs from the blood to receptors in the central nervous system (CNS).

All topic tags with their study counts